Quick Search:       Advanced Search
Chinese Version 
Online office
Journal Online
Download
Top
Links

扫描微信二维码,获取更多信息
Tanreqing Injection (痰热清注射液) for Patients with Influenza: A Systematic Review and Meta-analysis of Randomized Controlled Trials
  
View Full Text  View/Add Comment  Download reader
KeyWord:influenza, Tanreqing Injection, systematic review, meta-analysis, randomized controlled trial
Author NameAffiliationE-mail
QU Chen-chen,ZHAO Guo-zhen,WANG Xiao-peng   
LIU Qing-quan 1. Emergency Department of Beijing Hospital of Traditional Chinese Medicine, Capital Medical University, Beijing (100010), China
2. Beijing Institute of Traditional Chinese Medicine, Beijing (100010), China
3. Beijing Key Laboratory of Basic Research with Traditional Chinese Medicine on Infectious Diseases, Beijing (100010), China 
liuqingquan2003@126.com 
Hits: 611
Download times: 0
Abstract:
      Objective: To systematically evaluate the efficacy and safety of Tanreqing Injection (痰热清注射液, TRQI) combined with conventional treatment on clinical outcomes in the treatment of patients with influenza. Methods: The electronic databases searched were Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library), MEDLINE (PubMed), EMbase (OvidSP), Chinese Bio-medical Literature and Retrieval System (Sinomed), China National Knowledge Infrastructure Database (CNKI), China Science and Technology Journal Database (VIP) and WanFang Data Knowledge Service Platform, and we checked the reference sections of the retrieved articles as well. The search was performed in October 2018, and we used the randomized controlled trials (RCTs) that corresponded to the new diagnostic criteria for influenza. Two review authors independently screened the internalized articles in accordance with the Preferred Reporting Items for systematic review and Meta-Analysis (PRISMA) statement checklist. We evaluated the quality of the articles and extracted the data from the studies using the Revmen5.3 software. Results: We included 12 RCTs of over 882 cases in this meta-analysis. Compared to conventional treatment, TRQI combined with conventional treatment could increase the total effective rate [9 RCTs, n=648, odds ratio (OR): 4.92, 95% confidence interval (CI): 2.94, 8.24, P<0.0001, random effects model], decrease the average time for fever clearance [7 RCTs, n=564, mean difference (MD): –1.08, 95% CI: –1.68, –0.48, P=0.0004, random effects model] and decrease the time for resolution of cough (5 RCTs, n=362, MD: –1.76, 95% CI: –2.63, –0.90, P<0.0001, random effects model). Conclusion: Based on this meta-analysis of RCTs, TRQI combined with conventional treatment had a statistically significant benefit in increasing the total effective treatment rate and reducing the time for fever clearance as well as time for resolution of cough.
Close